Table 1.
Group 1 | Group 2 | Group 3 | |
---|---|---|---|
Sex |
|
|
|
Male/Female |
52/58 |
43/56 |
32/24 |
Age |
|
|
|
ASA |
32 |
22 |
7 |
I |
46 |
39 |
12 |
II |
21 |
26 |
21 |
III |
11 |
12 |
16 |
IV |
|
|
|
Comorbidity |
87 (79%) |
73 (74%) |
43 (77%) |
Cardiovascular |
34 (30%) |
24 (24%) |
21(37.5%) |
DM |
21 (19%) |
12 (12%) |
16(28.5%) |
Respiratory Disease |
8 (7.2%) |
5 (5%) |
9 (16%) |
Cerebrovascular Disease |
12 (11%) |
17 (17%) |
14 (25%) |
Others |
|
|
|
Presentation |
18 (16%) |
21 (21%) |
12 (21%) |
Asymptomatic |
92 (84%) |
78 (79%) |
44 (79%) |
Symptomatic |
14 (12%) |
23 (23%) |
13 (23%) |
Obstruction |
22 (19%) |
17 (17%) |
16 (28%) |
Anemia |
30 (30%) |
21 (21%) |
11 (19%) |
Blood in Stool Weight Loss |
26 (23%) |
17 (17%) |
4 (7%) |
Diagnostic |
23 (21%) |
32 (32%) |
16 (28%) |
Procedure |
78 (70%) |
60 (61%) |
32 (57%) |
Computerized Tomography |
9 (8%) |
7 (7%) |
8 (15%) |
Colonoscopy Exploration |